$FGEN FIBROGEN INC Insider Trading Week 10/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIBROGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FIBROGEN INC in week 10/2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 16 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Option Exercise | A | 53.75 | 55,000 | 2,956,250 | 55,000 | |
Mar 16 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Grant | A | 0.00 | 32,000 | 0 | 160,333 | 128.3 K to 160.3 K (+24.94 %) |
Mar 16 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 53.20 | 9,891 | 526,201 | 128,333 | 138.2 K to 128.3 K (-7.16 %) |
Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 9,000 | |
Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 52.78 | 300 | 15,834 | 29,000 | 29.3 K to 29 K (-1.02 %) |
Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 52.15 | 700 | 36,505 | 29,300 | 30 K to 29.3 K (-2.33 %) |
Mar 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 30,000 | 29 K to 30 K (+3.45 %) |
Mar 16 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | A | 53.75 | 110,000 | 5,912,500 | 110,000 | |
Mar 16 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Grant | A | 0.00 | 70,000 | 0 | 2,960,209 | 2.9 M to 3 M (+2.42 %) |
Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 4,000 | 11,600 | 4,000 | |
Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 53.05 | 1,100 | 58,355 | 20,000 | 21.1 K to 20 K (-5.21 %) |
Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 52.21 | 2,900 | 151,409 | 21,100 | 24 K to 21.1 K (-12.08 %) |
Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 2.90 | 4,000 | 11,600 | 24,000 | 20 K to 24 K (+20.00 %) |
Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 18.34 | 12,000 | 220,080 | 0 | |
Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 18.00 | 12,000 | 216,000 | 0 | |
Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Sell | S | 53.53 | 9,844 | 526,949 | 48,000 | 57.8 K to 48 K (-17.02 %) |
Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Sell | S | 53.26 | 14,156 | 753,949 | 57,844 | 72 K to 57.8 K (-19.66 %) |
Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 18.34 | 12,000 | 220,080 | 72,000 | 60 K to 72 K (+20.00 %) |
Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 18.00 | 12,000 | 216,000 | 60,000 | 48 K to 60 K (+25.00 %) |
Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 19.39 | 14,000 | 271,460 | 46,000 | |
Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 29.66 | 22,094 | 655,308 | 20,042 | |
Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | A | 53.75 | 38,000 | 2,042,500 | 38,000 | |
Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 53.08 | 13,804 | 732,716 | 196,334 | 210.1 K to 196.3 K (-6.57 %) |
Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 52.23 | 22,290 | 1,164,207 | 210,138 | 232.4 K to 210.1 K (-9.59 %) |
Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 29.66 | 22,094 | 655,308 | 232,428 | 210.3 K to 232.4 K (+10.50 %) |
Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 19.39 | 14,000 | 271,460 | 210,334 | 196.3 K to 210.3 K (+7.13 %) |
Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Grant | A | 0.00 | 28,000 | 0 | 196,334 | 168.3 K to 196.3 K (+16.63 %) |
Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 54.61 | 5,932 | 323,947 | 168,334 | 174.3 K to 168.3 K (-3.40 %) |
Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 55.19 | 2,618 | 144,487 | 379,200 | 381.8 K to 379.2 K (-0.69 %) |
Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 54.90 | 4,382 | 240,572 | 381,818 | 386.2 K to 381.8 K (-1.13 %) |
Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 53.07 | 5,402 | 286,684 | 386,200 | 391.6 K to 386.2 K (-1.38 %) |
Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 54.98 | 19,693 | 1,082,721 | 391,602 | 411.3 K to 391.6 K (-4.79 %) |
Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | M | 3.60 | 6,000 | 21,600 | 0 | |
Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | M | 3.60 | 12,000 | 43,200 | 0 | |
Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Sell | S | 55.00 | 18,000 | 990,000 | 135,064 | 153.1 K to 135.1 K (-11.76 %) |
Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Buy | M | 3.60 | 18,000 | 64,800 | 153,064 | 135.1 K to 153.1 K (+13.33 %) |
Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Gift | G | 0.00 | 500 | 0 | 135,064 | 135.6 K to 135.1 K (-0.37 %) |